Stay updated with breaking news from Hakic iol implant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results of the 30-month data cut of the 3-year GALE open-label extension trial of pegcetacoplan for geographic atrophy showed that the drug produced clinically meaningful reductions in lesion growth. ....